Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Renal Insufficiency,Type 2 Diabetes”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01200394
What this trial is testing

A Phase 2, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of PF-00489791 In Patients With Type 2 Diabetes And Overt Nephropathy

Who this might be right for
Diabetic Nephropathies
Pfizer 256
Not applicableTemporarily pausedNCT03921216
What this trial is testing

Cholesterol Metabolism in Plasma and Interstitial Fluid Among Subjects Undergoing Hemodialysis.

Who this might be right for
Diabetes Mellitus, Type 2Diabetic NephropathiesChronic Kidney Diseases
Karolinska University Hospital 20
Testing effectiveness (Phase 2)WithdrawnNCT01576887
What this trial is testing

A Double-Blind, Randomized, Placebo-Controlled Safety Study Evaluating the Effects of Residual Renal Function (RFF) in Patients With End-Stage Renal Disease and Type 2 Diabetes Mellitus on Peritoneal Dialysis

Who this might be right for
End-Stage Renal DiseaseType 2 Diabetes Mellitus
Biogen
Large-scale testing (Phase 3)Looking for participantsNCT07662135
What this trial is testing

A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin

Who this might be right for
Type 2 Diabetes MellitusType 2 Diabetes With Chronic Kidney Disease
AstraZeneca 900
Not applicableLooking for participantsNCT03569735
What this trial is testing

Nanshan Elderly Cohort Study

Who this might be right for
HypertensionType 2 Diabetes MellitusCardiovascular Diseases+7 more
Sun Yat-sen University 20,000
Early research (Phase 1)Study completedNCT04616027
What this trial is testing

STUDY OF PF-06882961 IN PARTICIPANTS WITH TYPE 2 DIABETES MELLITUS WITH VARYING DEGREES OF RENAL IMPAIRMENT AND PARTICIPANTS WITHOUT RENAL IMPAIRMENT

Who this might be right for
Diabetes Mellitus, Type 2Renal ImpairmentHealthy
Pfizer 42
Large-scale testing (Phase 3)Study completedNCT00509262
What this trial is testing

Sitagliptin Versus Glipizide in Participants With Type 2 Diabetes Mellitus and Chronic Renal Insufficiency (MK-0431-063 AM1)

Who this might be right for
Diabetes Mellitus, Type 2Renal Insufficiency, Chronic
Merck Sharp & Dohme LLC 426
Post-approval studies (Phase 4)Not Yet RecruitingNCT07667517
What this trial is testing

Finerenone for Regression of Albuminuria in Type 2 Diabetes With Chronic Kidney Disease

Who this might be right for
AlbuminuriaType 2 Diabetes Mellitus (T2DM)Chronic Kidney Diseases
First Affiliated Hospital of Zhejiang University 148
Large-scale testing (Phase 3)Study completedNCT02065791
What this trial is testing

Evaluation of the Effects of Canagliflozin on Renal and Cardiovascular Outcomes in Participants With Diabetic Nephropathy

Who this might be right for
Diabetes Mellitus, Type 2Diabetic Nephropathy
Janssen Research & Development, LLC 4,401
Testing effectiveness (Phase 2)Study completedNCT01843387
What this trial is testing

Safety and Efficacy of Mesenchymal Precursor Cells in Diabetic Nephropathy

Who this might be right for
Diabetic NephropathyType 2 Diabetes
Mesoblast, Ltd. 30
Testing effectiveness (Phase 2)Study completedNCT01487109
What this trial is testing

Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients

Who this might be right for
Type 2 Diabetes MellitusChronic Kidney Disease
Concert Pharmaceuticals 170
Early research (Phase 1)Study completedNCT00938158
What this trial is testing

The Pharmacokinetics of Albiglutide in Normal and Renally Impaired Subjects.

Who this might be right for
Diabetes Mellitus, Type 2
GlaxoSmithKline 75
Large-scale testing (Phase 3)Study completedNCT05803421
What this trial is testing

Daily Oral Orforglipron (LY3502970) Compared With Insulin Glargine in Participants With Type 2 Diabetes and Obesity or Overweight at Increased Cardiovascular Risk

Who this might be right for
Type 2 DiabetesObesityOverweight or Obesity+3 more
Eli Lilly and Company 2,749
Large-scale testing (Phase 3)Study completedNCT04865770
What this trial is testing

A Research Study to Find Out How Semaglutide Works in the Kidneys Compared to Placebo, in People With Type 2 Diabetes and Chronic Kidney Disease (the REMODEL Trial)

Who this might be right for
Diabetes Mellitus, Type 2Chronic Kidney Disease
Novo Nordisk A/S 106
Not applicableStudy completedNCT04790617
What this trial is testing

ENCOMPASS: Expansion Study B, RCT

Who this might be right for
HypertensionDiabetes Mellitus, Type 2Chronic Kidney Diseases+4 more
University of Calgary 183
Early research (Phase 1)Study completedNCT01464320
What this trial is testing

Evaluate the Safety and Tolerability of ABT-614 and Its Effect on Kidney Function in Subjects With Type 2 Diabetes and Chronic Kidney Disease With Protein in Their Urine.

Who this might be right for
Type 2 Diabetics, Chronic Kidney Disease, Protein in Urine
Abbott 16
Not applicableEnrolling By InvitationNCT07248891
What this trial is testing

Type 2 Diabetes and Associated Factors in Mexico

Who this might be right for
Diabetes Mellitus, Type 2Chronic Kidney DiseaseDiabetic Nephropathy
Coordinación de Investigación en Salud, Mexico 1,000
Not applicableLooking for participantsNCT07086989
What this trial is testing

Cardiovascular Risk in Children With Chronic Conditions Study

Who this might be right for
Kidney TransplantFamilial HypercholesterolaemiaType 1 Diabetes Mellitus (T1DM)+22 more
Semmelweis University 300
Post-approval studies (Phase 4)Study completedNCT00331162
What this trial is testing

Study of Alemtuzumab Versus Anti-thymocyte Globulin to Help Prevent Rejection in Kidney and Pancreas Transplantation

Who this might be right for
Graft Rejection
Wake Forest University Health Sciences 222
Not applicableStudy completedNCT07119892
What this trial is testing

Lifestyle Intervention and Its Effects on Inflammatory Cytokines and Oxidative Stress Markers in Diabetic Chronic Kidney Disease Patients: A Randomized Controlled Trial

Who this might be right for
Type 2 Diabetes MellitusInflammation, Chronic Low-GradeChronic Kidney Disease+2 more
Sinai University 60
Next Page